These seven genes have been used to predict the survival rate of NSCLC patients with “riskscore = ABHD5 * 0.2406 + HS3ST2 * -0.1412 + TM6SF1 * -0.3109 + CAPZA2 * 0.1895 + LEPROT * 0.2919 + HNMT * -0.1554 + MRO * 0.3260”. The gene discussed is CAPZA2; the disease is non-small cell lung carcinoma.